“Coherent Market Insights announced that it’s published an exclusive report namely Global U.S. Central Venous Catheter Market by Manufacturers, Regions, Type, and Application, Forecast to 2028 in its research database with report summary, table of content, research methodologies, and data sources. The research study offers a substantial knowledge platform for entrants and investors as well as veteran companies, manufacturers functioning in the Worldwide U.S. Central Venous Catheter Market. This is an informative study covering the market with an in-depth analysis and portraying the current state of affairs in the industry.”
Get Latest Insights in Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/2610
Central venous catheters play a vital role in modern healthcare. They are used to administer blood products, intravenous fluids, parenteral nutrition, and medicines, and offer hemodynamic monitoring and hemodialysis access. Central venous catheters can be used for longer duration therapies, such as end stage renal disease (dialysis) and cancer (chemotherapy).
The U.S. central venous catheter market size was valued at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018-2026).
High prevalence of cancer around the world is expected to augment the growth of the U.S. central venous catheter market over the forecast period. For instance, as pe the National Cancer Institute, 2013, there are over 100 different types of cancer that can be described by the type of cells from which they form. Furthermore, as per the American Cancer Society, cancer was the second leading cause of death, after heart disease, in the United States in 2017, accounting for around one out of 4 deaths.
Moreover, according to the Centers for Disease Control and Prevention (CDC), over 30 million American adults (15% of US population) is expected to have chronic kidney disease in 2017.
According to the World Health Organization (WHO), cancer was the second leading cause of mortality and morbidity around the world, with over 14 million new cases in 2012, and this number is expected to increase by around 70% by 2030.
Market players active in the global U.S. central venous catheter market are ICU Medical, Inc., Cook Medical, Inc., Theragenics Corporation, Vygon Ltd., Medtronic, B. Braun Melsungen, Teleflex Incorporated, C. R. Bard, Inc., AngioDynamics, Inc., and Argon Medical Devices, Inc., among others.
Market players are adopting various strategies, such as merger and acquisition, to enhance their market share or to strengthen their product portfolio. For instance, in 2017, Becton, Dickinson, and Company (BD) announced it has completed the acquisition of C. R. Bard, Inc. to create a new health care industry leader. Similarly, in July 2018, B. Braun Medical signed an agreement to acquire the bloodlines business of NxStage Medical, Inc.
Buy This Research Study Report (Flat US $2000 OFF) @ https://www.coherentmarketinsights.com/promo/buynow/2610
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027